This content is machine translated Myasthenia gravis Something is happening in the treatment management of autoimmune diseases Myasthenia gravis (or myasthenia for short) is a rare disease in which the immune system turns against its own body. Autoantibodies disrupt the transmission of impulses at the interface between…
View Post 10 min This content is machine translated GLP-1 agonists continue to gain ground Semaglutide in patients with obesity and heart failure It has long been known that the active ingredient class of glucagon-like peptide-1 agonists (GLP-1) reduces cardiovascular consequences in diabetics and leads to significant weight loss in patients with obesity.…
View Post 4 min This content is machine translated SGLT-2-i in type 2 diabetes and CVD Cardioprotective mechanisms of action of empagliflozin – what’s new? Empagliflozin is known to reduce the risk of atherosclerotic cardiovascular disease (CVD) in people with type 2 diabetes and high cardiovascular risk. The mechanisms underlying these effects are not yet…
View Post 4 min This content is machine translated AID systems for type 1 diabetes New real-world data shows: AI makes the difference In hybrid closed-loop systems, algorithms control the automated insulin delivery (AID). Compared to conventional insulin administration, this not only has a favorable effect on HbA1c values, but also on patient-oriented…
View Post 4 min This content is machine translated Dual GIP/GLP-1 RA in type 2 diabetes Tirzepatide proves multiple benefits In the Phase III SURPASS study program, the dual receptor agonist tirzepatide performed convincingly. The results of several post-hoc analyses are now also available. At the annual meeting of the…
View Post 6 min This content is machine translated Coronary heart disease and type 2 diabetes Relationship between baseline FFA values and all-cause mortality. It is known that elevated levels of free fatty acids (FFA) are strongly associated with all-cause mortality in patients with coronary heart disease (CHD) and the development of type 2…
View Post 3 min This content is machine translated Polyneuropathies Disorders of brain, spinal cord and nerve function Polyneuropathies are generalized diseases of the peripheral nervous system. With a prevalence of 5-8%, patients with chronic alcohol abuse, diabetes or malignant diseases are most affected. In addition to treatment…
View Post 4 min This content is machine translated Obesity Incretin mimetics close therapeutic gap Dietary changes and exercise often prove insufficient as measures against morbid obesity. Until now, bariatric surgery has been the only goal-oriented measure for many obese patients. This has changed in…
View Post 5 min This content is machine translated CKD in type 2 diabetes Cardiorenal protection in focus – using modern therapy options Type 2 diabetics can lead a relatively normal life if they adhere to therapy guidelines and maintain HbA1c levels for as many years as possible.are in the target area. Conversely,…
View Post 6 min This content is machine translated Latent hypothyroidism Indication for hormone substitution? In everyday practice, elevated TSH values are usually detected by chance during a routine examination. If the finding is confirmed by a repeat measurement, but the values for free T3…
View Post 7 min This content is machine translated Type 1 diabetes Chronic hyperglycemia promotes atherosclerosis A recent study investigated whether chronic hyperglycemia in type 1 diabetes is associated with a proinflammatory immune signature and arterial wall inflammation that promotes the development of atherosclerosis.
